Literature DB >> 8540457

Sympathetic reinnervation after acute myocardial infarction.

J Hartikainen1, J Kuikka, M Mäntysaari, E Länsimies, K Pyörälä.   

Abstract

Myocardial infarction produces sympathetic denervation of the necrotic myocardium and noninfarcted myocardium apical to the injury. Proof of sympathetic reinnervation after myocardial infarction has, however, remained elusive. In this study, we investigated whether cardiac sympathetic reinnervation occurs in men recovering from myocardial infarction. I-123 metaiodobenzylguanidine (MIBG), I-123 paraphenylpentadecanoic acid, and Tc-99m sestamibi scintigraphic imaging were conducted in 13 men 3 and 12 months after a first myocardial infarction to determine the extent of denervated myocardium, the size of the infarct, and the size of the myocardium with reduced perfusion, respectively. A defect was determined as regional uptake of < or = 30% of the maximal myocardial activity. The size of the MIBG defect was not significantly different between 3 and 12 months after infarction (17 +/- 8% and 18 +/- 8% of left ventricular mass, respectively). There was also no significant change in the extent of viable but denervated myocardium at 3 and 12 months (average 9 +/- 6% and 10 +/- 5%, respectively). MIBG activity of the infarct zone (expressed as a percentage of MIBG activity of the myocardium with normal perfusion) did not change (17 +/- 13% and 20 +/- 16%), whereas MIBG activity of the periinfarct zone increased during follow-up (32 +/- 11% and 41 +/- 14%, p < 0.01). This was associated with an increase in periinfarct I-123 paraphenylpentadecanoic acid activity (40 +/- 11% and 48 +/- 9%, p < 0.05), but not Tc-99m sestamibi activity (48 +/- 10% and 48 +/- 11%). In conclusion, we did not observe sympathetic reinnervation in the infarct zone between 3 and 12 months after myocardial infarction. However, MIBG activity of the periinfarct zone increased, suggesting partial reinnervation, and this was associated with a recovery of myocardial metabolic activity of the periinfarct zone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8540457     DOI: 10.1016/s0002-9149(97)89125-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

Review 1.  MIBG imaging.

Authors:  Amar D Patel; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

Review 2.  Cardiac neurotransmission SPECT imaging.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

3.  123I-MIBG myocardial scintigraphy as a noninvasive screen for the diagnosis of coronary artery spasm.

Authors:  J W Ha; J D Lee; Y Jang; N Chung; J Kwan; S J Rim; Y J Lee; W H Shim; S Y Cho; S S Kim
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

4.  Sympathetic nerve damage and restoration after ischemia-reperfusion injury as assessed by (11)C-hydroxyephedrine.

Authors:  Rudolf A Werner; Yoshifumi Maya; Christoph Rischpler; Mehrbod S Javadi; Kazuhito Fukushima; Constantin Lapa; Ken Herrmann; Takahiro Higuchi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-21       Impact factor: 9.236

5.  Optimization of a simultaneous dual-isotope 201Tl/123I-MIBG myocardial SPECT imaging protocol with a CZT camera for trigger zone assessment after myocardial infarction for routine clinical settings: Are delayed acquisition and scatter correction necessary?

Authors:  Emmanuel D'estanque; Christophe Hedon; Benoît Lattuca; Aurélie Bourdon; Meriem Benkiran; Aurélie Verd; François Roubille; Denis Mariano-Goulart
Journal:  J Nucl Cardiol       Date:  2016-05-25       Impact factor: 5.952

6.  Myocardial sympathetic innervation in patients with chronic coronary artery disease: is reduction in coronary flow reserve correlated with sympathetic denervation?

Authors:  Eva Fricke; Harald Fricke; Siegfried Eckert; Sytze Zijlstra; Reiner Weise; Oliver Lindner; Dieter Horstkotte; Wolfgang Burchert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-23       Impact factor: 9.236

Review 7.  Dysinnervated but viable myocardium in ischemic heart disease.

Authors:  James A Fallavollita; John M Canty
Journal:  J Nucl Cardiol       Date:  2010-12       Impact factor: 5.952

8.  Neuronal dysfunction in heart failure assessed by cardiac 123-iodine metaiodobenzylguanidine scintigraphy.

Authors:  G A Somsen; E E van der Wall; B van Vlies; J J Borm; E A van Royen
Journal:  Int J Card Imaging       Date:  1996-12

9.  11C-meta-hydroxyephedrine defects persist despite functional improvement in hibernating myocardium.

Authors:  James A Fallavollita; Michael D Banas; Gen Suzuki; Robert A deKemp; Munawwar Sajjad; John M Canty
Journal:  J Nucl Cardiol       Date:  2009-11-10       Impact factor: 5.952

10.  Infarct-derived chondroitin sulfate proteoglycans prevent sympathetic reinnervation after cardiac ischemia-reperfusion injury.

Authors:  Ryan T Gardner; Beth A Habecker
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.